Table: Fuji Pharmaceutical - 6-MTH group results

Fuji Pharma

11/05/2023 09:00

May 11 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Mar 31, 2023        Mar 31, 2022     Sep 30, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             19.23               17.73            43.31    
                 (+8.5 pct)          (+2.6 pct)       (+22.3 pct) 
  Operating          1.82                2.71             4.05    
                 (-32.7 pct)         (+1.0 pct)       (+7.2 pct)  
  Recurring          2.46                2.87             4.09    
                 (-14.3 pct)         (+4.7 pct)       (+9.7 pct)  
  Net                1.77                1.83             2.97    
                 (-3.3 pct)          (-9.3 pct)       (+10.3 pct) 
  EPS             72.95 yen           75.50 yen       122.42 yen  
  Ann Div                             35.00 yen        37.00 yen  
  -Q2 div         17.00 yen           15.00 yen                   
  -Q4 div                             20.00 yen        20.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T